K190851

Substantially Equivalent

HYDRASHIFT 2/4 daratumumab

Applicant: Sebia
Product code: CFF
Advisory panel: Immunology
Date received: 2019-04-02
Decision date: 2019-05-02
Decision: Substantially Equivalent
Clearance type: Special
Location: Norcross, GA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.